On December 16, the 2023 New Chinese Medicine Translational Medicine Forum was held in Chengdu. The forum was jointly sponsored by the World Federation of Chinese Medicine Societies (hereinafter referred to as the World Federation of Chinese Medicine Societies) Chinese Medicine New Drug Creation Professional Committee, the Chinese Pharmaceutical Association Chinese Medicine Clinical Evaluation Professional Committee, the Sichuan Pharmacology Society, and the Chinese Medicine Pharmaceutical Engineering Branch of the China Association of Chinese Medicine. Xu Xu, Secretary of the Party Committee of Sichuan Academy of Traditional Chinese Medicine, Zhou Quan, Deputy Director of Sichuan Provincial Drug Administration, Li Bo, Vice President of Chinese Pharmaceutical Association, and other leading guests attended the opening ceremony and delivered speeches. With the theme of "Transformation of New Chinese Medicine", the conference attracted more than 300 people from all over the country, including industry experts, Chinese medicine entrepreneurs, and Chinese medicine social organizations.
Opening Ceremony of the General Assembly
Director Tian Xingjun delivered a speech
Secretary Xu Xu delivered a speech.
Deputy Director Zhou Quan delivered a speech.
Vice Chairman Li Bo delivered a speech.
Vice President Tang Jianyuan presided over the opening ceremony
Seven experts and scholars were invited to give keynote speeches at the main venue. Ding Jian, academician of the Chinese Academy of Engineering and researcher of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, made a keynote report entitled "Thirty Years of R&D of New Anti-tumor Drugs", which made an in-depth analysis of the current situation, challenges, and future development trends of anti-tumor drugs in China. Chen Shilin, academician of the Chinese Academy of Engineering and chief professor of Chengdu University of Traditional Chinese Medicine, gave a keynote report entitled "Construction of the Underlying Core Technology of Traditional Chinese Medicine Research", and is committed to establishing a modern Chinese medicine discovery and evaluation system based on genome-wide pan-GPR, creating a "GPCR business card" with global influence, and helping to "modernize traditional Chinese medicine". Cheng Yiyu, a professor at the School of Pharmacy of Zhejiang University, gave a keynote report entitled "New Progress in the Intelligent Creation of New Chinese Medicine Drugs and AI Pharmaceutical Technology Research", and elaborated on the application of AI in the transformation of new Chinese medicine drugs through examples of AI-based drug target discovery, design and registration of new Chinese medicines. Wang Yitao, chair professor of the University of Macau, gave a keynote report entitled "Innovative R&D and International Expansion of Traditional Chinese Medicine", Yang Zhongqi, professor of the First Affiliated Hospital of Guangzhou University of Chinese Medicine, gave a keynote report entitled "Research and Development of Traditional Chinese Medicine under the Evaluation System of Chinese Medicine", Xie Yuansheng, professor of the General Hospital of the People's Liberation Army and the School of Medicine of Nankai University, gave a keynote report entitled "Reflections on Clinical Research of Integrated Traditional Chinese and Western Medicine", and Zhao Limei, professor of the Department of Pharmacy of Shengjing Hospital affiliated to China Medical University, gave a keynote report entitled "Clinical Research and Output Based on Drug Safety" Keynote Speech.
Experts made keynote speeches
At the venue of new drug creation of traditional Chinese medicine, 11 experts and scholars were invited to give a keynote report on "clinical orientation, quality control, new technologies and new methods of new drug creation of traditional Chinese medicine". Liu Jianxun, chief researcher of the China Academy of Chinese Medical Sciences, gave a keynote report entitled "Research and Evaluation of the Efficacy of New Compound Chinese Medicine", Chen Daofeng, a distinguished professor of Fudan University, gave a keynote report entitled "The Immune Regulation Mechanism of Lung Infection in Traditional Chinese Medicine", Yi Jinhai, chief scientist of Sichuan Academy of Traditional Chinese Medicine, gave a keynote report entitled "Research and Thinking on Innovative Chinese Medicine", and Fan Xiaohui, Qiushi Distinguished Professor of Zhejiang University, gave a keynote report entitled "Cross-innovation Helps the High-quality Development of Traditional Chinese Medicine Industry" Wang Yu, professor of Jiangsu Institute of Food and Drug Supervision and Control, gave a keynote report entitled "Technical and Regulatory Considerations for ICHQ12 Drug Life Cycle Management", Wang Yi, professor of the School of Pharmacy of Zhejiang University, gave a keynote report entitled "Technical and Regulatory Considerations for ICHQ12 Drug Life Cycle Management", Wang Yuefei, professor of Tianjin University of Traditional Chinese Medicine, gave a keynote report entitled "Panoramic Analysis and Application of Psoralen Quality Characteristics", and Tao Yiran, Ph.D. from West China Hospital of Sichuan University, gave a keynote report entitled " Research on blood sugar regulation of Caoguo on diabetic mice", Liu Yude, chairman of Ping An Jincun Traditional Chinese Medicine Science and Technology, made a keynote report entitled "The Construction of Evidence-based Medicine Research on Tsumura Chinese Medicine", and Dr. Chen Ruiqing, Ph.D., Institute of Pharmacology, National Taiwan University School of Medicine, gave a keynote report entitled "China's First Natural Medicine 1".Yang Zifeng, a professor from the First Affiliated Hospital of Guangzhou Medical University, gave a keynote report entitled "Construction of Animal Models for Emerging Viruses and Research Practice of Antiviral in Traditional Chinese Medicine".
The conference set up four academic sub-forums, including the discussion on clinical research and evaluation methodology of traditional Chinese medicine, the creation of new drugs in traditional Chinese medicine, pharmacology and smart pharmaceutical. The topics of this forum focus on the cutting-edge trends and research hotspots and difficulties in the development of traditional Chinese medicine, including the future expectations for the transformation of new Chinese medicine drugs at the macro level, the development trend of the industry, and the sharing and interpretation of specific landing casesThere are the latest advances in cutting-edge technologies, as well as hot topics such as oncology drug research and development, intelligent manufacturing of traditional Chinese medicine, transformation of traditional Chinese medicine guided by clinical value, internationalization of traditional Chinese medicine, and safe drug useIt not only provides an academic exchange platform for industry experts, scholars and enterprises to jointly promote the development of the new Chinese medicine industry, but also further promotes practitioners to broaden their horizons, expand their knowledge and give new strength in the integration of diverse professional knowledge. Let the theoretical knowledge be applied to practice, so that science and technology can empower the "new growth point" of traditional Chinese medicine, and jointly help the innovation and high-quality development of the new Chinese medicine industry.